Bernstein analyst Lance Wilkes raised the firm’s price target on Centene (CNC) to $45 from $36 and keeps an Outperform rating on the shares after the company reported Q3 results. The firm sees margin recovery in Marketplace and Medicaid as driving outsized EPS growth with pricing largely addressing risk adjustment in Marketplace and risk pool shifts over the 2026/2027 time period. The firm added that it expects Medicaid margins remaining under pressure in 2026 and then normalizing over 2027-2029.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- Midday Fly By: Microsoft, Nvidia invest in Anthropic
- Trump Trade: President says U.S. planning to sell F-35 jets to Saudi Arabia
- Trump says health insurance companies have ‘ripped off America long enough’
- Einhorn’s DME Capital bought PG&E and United Parks in Q3
- Trump Weekly: President set to cut tariffs on beef, coffee